OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Significance of Heme Oxygenase 1 in Tumor Progression
Mariapaola Nitti, Caterina Ivaldo, Nicola Traverso, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 789-789
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Flavonoids with Anti-Angiogenesis Function in Cancer
Qiang Wei, Yihan Zhang
Molecules (2024) Vol. 29, Iss. 7, pp. 1570-1570
Open Access | Times Cited: 11

Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells
Lu Han, Lei Li, Geng Wu
Molecular and Cellular Probes (2022) Vol. 64, pp. 101821-101821
Closed Access | Times Cited: 31

Hormesis and Oxidative Distress: Pathophysiology of Reactive Oxygen Species and the Open Question of Antioxidant Modulation and Supplementation
Mariapaola Nitti, Barbara Marengo, Anna Lisa Furfaro, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1613-1613
Open Access | Times Cited: 31

Benzo[a]pyrene treatment modulates Nrf2/Keap1 axis and changes the metabolic profile in rat lung cancer
Kaveri R. Washimkar, Manendra Singh Tomar, Sharmeen Ishteyaque, et al.
Chemico-Biological Interactions (2023) Vol. 373, pp. 110373-110373
Closed Access | Times Cited: 13

Fisetin as a chemoprotective and chemotherapeutic agent: mechanistic insights and future directions in cancer therapy
Rabab Fatima, Priyal Soni, Mousmee Sharma, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access

Synergistic effects of HO-1 inhibition and chemotherapy on tumor proliferation and immune infiltration: An in vitro and in vivo approach to enhancing prostate cancer treatment
Ramia J. Salloom, Dania Z. Sahtout, Iman M. Ahmad, et al.
Translational Oncology (2025) Vol. 54, pp. 102339-102339
Closed Access

The dual role and mutual dependence of heme/HO-1/Bach1 axis in the carcinogenic and anti-carcinogenic intersection
Jinjing Xu, Kuiyang Zhu, Yali Wang, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 1, pp. 483-501
Closed Access | Times Cited: 16

Pharmacological Significance of Heme Oxygenase 1 in Prostate Cancer
Mohamed Ben‐Eltriki, Erysa J. Gayle, Noah Walker, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 5, pp. 4301-4316
Open Access | Times Cited: 10

Biliverdin as a disease-modifying agent: An integrated viewpoint
Cesare Mancuso
Free Radical Biology and Medicine (2023) Vol. 207, pp. 133-143
Closed Access | Times Cited: 9

Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer
Junping Fan, Bo Chen, Xingqiang Lü, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116312-116312
Open Access | Times Cited: 3

The Pharmacological Effect of Hemin in Inflammatory-Related Diseases: A Systematic Review
João Estarreja, Gonçalo Caldeira, Inês Silva, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 898-898
Open Access | Times Cited: 3

Novel Acetamide-Based HO-1 Inhibitor Counteracts Glioblastoma Progression by Interfering with the Hypoxic–Angiogenic Pathway
Agata Grazia D’Amico, Grazia Maugeri, Luca Vanella, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5389-5389
Open Access | Times Cited: 3

Molecular pathway of anticancer effect of next-generation HSP90 inhibitors XL-888 and Debio0932 in neuroblastoma cell line
Özlem Kaplan, Nazan Gökşen Tosun
Medical Oncology (2024) Vol. 41, Iss. 8
Open Access | Times Cited: 3

Article review: Brazilin as potential anticancer agent
Callista Najla Raptania, Syifa Zakia, Alistia Ilmiah Fahira, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Integrating Mitochondrial Biology into Innovative Cell Therapies for Neurodegenerative Diseases
A. Ore, James M. Angelastro, Cecilia Giulivi
Brain Sciences (2024) Vol. 14, Iss. 9, pp. 899-899
Open Access | Times Cited: 2

The NRF-2/HO-1 Signaling Pathway: A Promising Therapeutic Target for Metabolic Dysfunction-Associated Steatotic Liver Disease
Na Li, Liyuan Hao, Shenghao Li, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 8061-8083
Open Access | Times Cited: 2

An Analysis of the Multifaceted Roles of Heme in the Pathogenesis of Cancer and Related Diseases
Tianyuan Wang, Adnin Ashrafi, Pouya Modareszadeh, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4142-4142
Open Access | Times Cited: 14

Magnolol Triggers Caspase-Mediated Apoptotic Cell Death in Human Oral Cancer Cells through JNK1/2 and p38 Pathways
Yi‐Tzu Chen, Chiao‐Wen Lin, Chun‐Wen Su, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1295-1295
Open Access | Times Cited: 14

Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction via Activating PPARγ and PGC1α
Yufei Zhou, Ting Yin, Mengsha Shi, et al.
PPAR Research (2021) Vol. 2021, pp. 1-17
Open Access | Times Cited: 13

Page 1 - Next Page

Scroll to top